Smoking is not associated with nonalcoholic fatty liver disease

World Journal of Gastroenterology

Volumn 12, Issue 32, 2006, Pages 5196-5200

  Chavez Tapia, Norberto C ^a   Lizardi Cervera, Javier ^a   Perez Bautista, Oliver ^a   Ramos Ostos, Martha H ^a   Uribe, Misael ^a  

^a LIVER RESEARCH UNIT   (Mexico)

Author keywords

Metabolic syndrome; Nonalcoholic fatty liver disease; Smoking

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHEMICAL PARAMETERS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE CLASSIFICATION; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MEXICO; NONALCOHOLIC FATTY LIVER; PREVALENCE; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL;

EID: 33748516578     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-1110
2. Mendez-Sanchez N, Chavez-Tapia NC, Uribe M. Obesity and non-alcoholic steatohepatitis. Gac Med Mex 2004; 140 Suppl 2: S67-72
3. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994; 74: 761-811
4. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance: J Clin Invest 1995; 95: 2409-2415
5. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004; 89: 2563-2568
6. Day CP, James OF. Hepatic steatosis: innocent bystander or guilty party? Hepatology 1998; 27: 1463-1466
7. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610-614
8. von Eyben FE, Zeeman G. Health risk from active and passive smoking. Rev Esp Salud Publica 2003; 77: 11-36
9. den Tonkelaar I, Seidell JC, van Noord PA, Baanders-van Halewijn EA, Ouwehand IJ. Fat distribution in relation to age, degree of obesity, smoking habits, parity and estrogen use: a cross-sectional study in 11,825 Dutch women participating in the DOM-project. Int J Obes 1990; 14: 753-761
10. Kong C, Nimmo L, Elatrozy T, Anyaoku V, Hughes C, Robinson S, Richmond W, Elkeles RS. Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis 2001; 156: 373-378
11. Avti PK, Kumar S, Pathak CM, Vaiphei K, Khanduja KL. Smokeless tobacco impairs the antioxidant defense in liver, lung, and kidney of rats. Toxicol Sci 2006; 89: 547-553
12. Zhang J, Liu Y, Shi J, Larson DF, Watson RR. Side-stream cigarette smoke induces dose-response in systemic inflammatory cytokine production and oxidative stress. Exp Biol Med (Maywood) 2002; 227: 823-913
13. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005; 42: 218-224
14. Chen ZM, Liu BQ, Boreham J, Wu YP, Chen JS, Peto R. Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths. Int J Cancer 2003; 107: 106-112
15. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
16. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
18. Kim HS, Kwack SJ, Lee BM. Alteration of cytochrorne P-450 and glutathione S-transferase activity in normal and malignant human stomach. J Toxicol Environ Health A 2005; 68: 1611-1620
19. Eke BC, Iscan M. Effects of cigarette smoke with different tar contents on hepatic and pulmonary xenobiotic metabolizing enzymes in rats. Hum Exp Toxicol 2002; 21: 17-23
20. Attolini L, Gantenbein M, Villard PH, Lacarelle B, Catalin J, Bruguerolle B. Effects of different exposure times to tobacco smoke intoxication on carboxyhemoglobin and hepatic enzymate activities in mice. J Pharmacol Toxicol Methods 1996; 35: 211-215
21. Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, Rueff B, Valla DC, Degos F. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 2001; 34: 121-125
22. Corrao G, Lepore AR, Torchio P, Valenti M, Galatola G, D'Amicis A, Arico S, di Orio F. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease. Eur J Epidemiol 1994; 10: 657-664
23. Suzuki A, Lindor K, St Saver J, Lymp J, Mendes F, Muto A, Okada T, Angulo P. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005; 43: 1060-1066
24. Foy CG, Bell RA, Farmer DF, Goff DC Jr, Wagenknecht LE. Smoking and incidence of diabetes among U.S. adults: findings from the Insulin Resistance Atherosclerosis Study. Diabetes Care 2005; 28: 2501-2507
25. Mendez-Sanchez N, Chavez-Tapia NC, Uribe M. [An update on non-alcoholic fatty liver disease] Rev Invest Clin 2004; 56: 72-82
26. Komiya H, Mori Y, Yokose T, Tajima N. Smoking as a risk factor for visceral fat accumulation in Japanese men. Tohoku J Exp Med 2006; 208: 123-132
27. Ehrenberg HM, Huston-Presley L, Catalano PM. The influence of obesity and gestational diabetes mellitus on accretion and the distribution of adipose tissue in pregnancy. Am J Obstet Gynecol 2003; 189: 944-948
28. Thomas GN, Ho SY, Lam KS, Janus ED, Hedley AJ, Lam TH. Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese. Obes Res 2004; 12: 1805-1813
29. Tulloch-Reid MK, Williams DE, Looker HC, Hanson RL, Knowler WC. Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Comparison of anthropometric predictors of type 2 diabetes in Pima Indians. Diabetes Care 2003; 26: 2556-2561
30. Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003; 285: E906-916
31. Masulli M, Riccardi G, Galasso R, Vaccaro O. Relationship between smoking habits and the features of the metabolic syndrome in a non-diabetic population. Nutr Metab Cardiovasc Dis 2006; 16: 364-370
32. Ostgren CJ, Lindblad U, Ranstam J, Melander A, Rastam L. Associations between smoking and beta-cell function in a non-hypertensive and non-diabetic population. Skaraborg Hypertension and Diabetes Project. Diabet Med 2000; 17: 445-450
33. Tziomalos K, Charsoulis F. Endocrine effects of tobacco smoking. Clin Endocrinol (Oxf) 2004; 61: 664-674
34. Hayes L, Pearce MS, Unwin NC. Lifecourse predictors of normal metabolic parameters in overweight and obese adults. Int J Obes (Lond) 2006; 30: 970-976